Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Staphylococcus aureus (strain N315) | Probable nicotinate-nucleotide adenylyltransferase | Starlite/ChEMBL | No references |
Plasmodium falciparum | M17 leucyl aminopeptidase | Starlite/ChEMBL | No references |
Homo sapiens | lysine (K)-specific methyltransferase 2A | Starlite/ChEMBL | No references |
Homo sapiens | multiple endocrine neoplasia I | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0044 | 1 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0008 | 0.0044 | 1 |
Echinococcus multilocularis | leucyl aminopeptidase | 0.0025 | 0.0255 | 0.0203 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0044 | 1 |
Echinococcus granulosus | cpg binding protein | 0.0037 | 0.0391 | 0.034 |
Plasmodium falciparum | nicotinamide/nicotinic acid mononucleotide adenylyltransferase | 0.0345 | 0.4105 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0044 | 1 |
Leishmania major | cytosolic leucyl aminopeptidase,metallo-peptidase, Clan MF, Family M17 | 0.0127 | 0.1486 | 1 |
Trypanosoma cruzi | cytosolic leucyl aminopeptidase, putative | 0.0127 | 0.1486 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0035 | 0.0367 | 0.0359 |
Mycobacterium tuberculosis | Probable nicotinate-nucleotide adenylyltransferase NadD (deamido-NAD(+) pyrophosphorylase) (deamido-NAD(+) diphosphorylase) (nic | 0.0345 | 0.4105 | 1 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0044 | 1 |
Brugia malayi | Aminopeptidase W07G4.4 in chromosome V | 0.0025 | 0.0255 | 0.6146 |
Wolbachia endosymbiont of Brugia malayi | leucyl aminopeptidase | 0.0127 | 0.1486 | 0.5 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0079 | 0.0026 |
Schistosoma mansoni | hypothetical protein | 0.0494 | 0.5907 | 0.5903 |
Echinococcus granulosus | ankyrin repeat domain containing protein 17 | 0.0025 | 0.0255 | 0.0203 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.0391 | 0.0382 |
Loa Loa (eye worm) | aminopeptidase in chromosome III | 0.0025 | 0.0255 | 0.6124 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0044 | 1 |
Schistosoma mansoni | PwLAP aminopeptidase (M17 family) | 0.0025 | 0.0255 | 0.0247 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0044 | 1 |
Echinococcus granulosus | dnaJ subfamily B | 0.0494 | 0.5907 | 0.5885 |
Echinococcus granulosus | leucyl aminopeptidase | 0.0025 | 0.0255 | 0.0203 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0079 | 0.0026 |
Onchocerca volvulus | 0.0035 | 0.0367 | 0.5 | |
Trypanosoma brucei | metallo-peptidase, Clan MF, Family M17 | 0.0127 | 0.1486 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0044 | 1 |
Treponema pallidum | hypothetical protein | 0.0345 | 0.4105 | 0.5 |
Toxoplasma gondii | leucyl aminopeptidase LAP | 0.0127 | 0.1486 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0044 | 1 |
Echinococcus multilocularis | dnaJ subfamily B | 0.0494 | 0.5907 | 0.5885 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0044 | 1 |
Mycobacterium ulcerans | bifunctional nicotinate-nucleotide adenylyltransferase NadD/hypothetical protein | 0.0345 | 0.4105 | 1 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 1 | 1 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0044 | 1 |
Echinococcus granulosus | leucyl aminopeptidase | 0.0025 | 0.0255 | 0.0203 |
Echinococcus multilocularis | leucine aminopeptidase protein | 0.0127 | 0.1486 | 0.1441 |
Chlamydia trachomatis | cytosol aminopeptidase | 0.0127 | 0.1486 | 0.5 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0035 | 0.0367 | 1 |
Loa Loa (eye worm) | aminopeptidase in chromosome V | 0.0025 | 0.0255 | 0.6124 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0044 | 1 |
Brugia malayi | Ubiquitin carboxyl-terminal hydrolase family protein | 0.0025 | 0.0255 | 0.6146 |
Echinococcus multilocularis | leucyl aminopeptidase | 0.0025 | 0.0255 | 0.0203 |
Brugia malayi | CXXC zinc finger family protein | 0.0035 | 0.0367 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.0391 | 0.0382 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0074 | 0.0836 | 0.0828 |
Brugia malayi | Aminopeptidase ZK353.6 in chromosome III | 0.0025 | 0.0255 | 0.6146 |
Schistosoma mansoni | leucine aminopeptidase | 0.0025 | 0.0255 | 0.0247 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0044 | 1 |
Echinococcus multilocularis | leucyl aminopeptidase | 0.0025 | 0.0255 | 0.0203 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 1 | 1 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0008 | 0.0044 | 1 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0009 | 0.0053 | 0.0044 |
Trypanosoma cruzi | metallo-peptidase, Clan MF, Family M17, putative | 0.0127 | 0.1486 | 1 |
Trichomonas vaginalis | helicase, putative | 0.0008 | 0.0044 | 1 |
Plasmodium vivax | nicotinate-nucleotide adenylyltransferase, putative | 0.0345 | 0.4105 | 1 |
Echinococcus multilocularis | cpg binding protein | 0.0037 | 0.0391 | 0.034 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0044 | 1 |
Brugia malayi | cytosol aminopeptidase | 0.0025 | 0.0255 | 0.6146 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0044 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0044 | 1 |
Echinococcus granulosus | leucine aminopeptidase protein | 0.0127 | 0.1486 | 0.1441 |
Mycobacterium leprae | PROBABLE NICOTINATE-NUCLEOTIDE ADENYLYLTRANSFERASE NADD (DEAMIDO-NAD(+) PYROPHOSPHORYLASE) (DEAMIDO-NAD(+) DIPHOSPHORYLASE) (NIC | 0.0345 | 0.4105 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 1.41 um | PUBCHEM_BIOASSAY: Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP). (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | 15.3 uM | PubChem BioAssay. Dose response confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | 42.4 uM | PubChem BioAssay. Dose response confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay - Set 2. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (binding) | > 59.642 um | PUBCHEM_BIOASSAY: Counterscreen for inhibitors of M1 and M17 aminopeptidases: QFRET-based biochemical high throughput dose response assay for inhibitors of the Cathepsin L proteinase (CTSL1). (Class of assay: confirmatory) [Related pubchem assays: 1619 (Screening assay (M17LAP inhibitors).), 1445 (Screening Assay (M1AAP inhibitors).)] | ChEMBL. | No reference |
IC50 (binding) | > 73.456 um | PUBCHEM_BIOASSAY: Counterscreen for inhibitors of M1 and M17 aminopeptidases: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). (Class of assay: confirmatory) [Related PubChem assays: 1619 (Screening assay (M17LAP inhibitors).), 1445 (Screening assay (M1AAP inhibitors).)] | ChEMBL. | No reference |
Potency (functional) | 14.7157 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (binding) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 37.933 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.